CA
NZ
UK
AU
IND
US
Reynolds Consumer Products disclosed its second quarter 2026 financial performance on July 29, 2026, presenting operational results across its four primary business segments. The company operates through Reynolds Cooking and Kitchen Essentials, Hefty Waste and Cleanup, Hefty Home and Tableware, and Hefty Storage and …
Cognizant Technology Solutions Corporation, a leading provider of professional services and digital transformation consulting, filed its second quarter 2026 financial disclosure covering the period ending June 30, 2026. The company operates across multiple service segments including Health Sciences, Financial Services, Products and Resources, and …
Reynolds Consumer Products Inc. disclosed its financial results for the second quarter ended June 30, 2026, through an announcement on July 29, 2026. The company, which manufactures and distributes consumer products across multiple categories, provided operational and financial updates for the period. Investors have …
U.S. Central Command said it intercepted multiple ballistic missiles after Iran launched a surprise attack on American forces in the Gulf, raising fears that fighting could resume after a days-long pause. Alongside Saudi forces, the U.S. carried out strikes on Iran-aligned terrorists in Iraq. …
Novocure (NASDAQ: NVCR) shares closed up 28% at $19.99 after the company reported Q2 2026 net revenue of $183.58 million, up 16% year-over-year and beating the $172.44 million consensus estimate, in one of the sharpest single-day rallies among biopharma names this session.
KALA BIO, Inc. (NASDAQ: KALA) shares closed down 17% at $0.61 after the company submitted a prospectus supplement for an at-the-market equity offering to potentially sell as much as $250 million in common stock.
Neuphoria Therapeutics (NASDAQ: NEUP) shares closed up 18% at $3.92 after the company and Scancell Holdings plc (AIM: SCLP) finalized an agreement for an all-stock merger, one of the more significant corporate actions among the disclosed biopharma names this session.
China SXT Pharmaceuticals (NASDAQ: SXTC) shares closed down 84% at $0.33 after the company announced a $9 million registered direct offering, one of the most severe single-day declines among the disclosed biopharma names this session.
MindWalk Holdings (NASDAQ: HYFT) shares closed down 18% at $1.18 after the company reported a quarterly loss of $0.06 per share, missing the $0.05 consensus by 20%.
A cluster of biopharma names moved sharply in the same session on a wide range of corporate, clinical, and financing news, spanning one standout earnings-driven rally, one severe dilution-driven collapse, a finalized cross-border merger, and five separate declines tied to financing actions, an earnings …
Please wait processing your request...